Table 1.
Characteristics of all ET2DS participants, those undergoing CK18 and steatosis assessment and subgroups with ELF measurements
| Characteristic | All participants (n = 1,033) |
CK18 and steatosis participants (n = 858) |
ELF participants (n = 679) |
|---|---|---|---|
| Age, years | 67.9 (4.2) | 67.9 (4.2) | 67.8 (4.2) |
| Sex, % male | 51.2 (530) | 53.8 (462) | 52.6 (357) |
| Duration of diabetes, years | 6.0 (3.0–11.0) | 6.0 (3.0–11.0) | 6.0 (3.0–10.0) |
| HbA1c, % | 7.39 (1.1) | 7.38 (1.1) | 7.36 (1.1) |
| HbA1c, mmol/mol | 57.0 (12.1) | 57.2 (12.3) | 57.0 (11.9) |
| Fasting glucose, mmol/l | 7.54 (2.1) | 7.48 (2.0) | 7.49 (2.0) |
| Diet-controlled, % yes | 19.8 (197) | 19.3 (161) | 19.2 (127) |
| Oral antihyperglycaemic agent use, % yes | 63.0 (628) | 64.8 (541) | 65.4 (432) |
| Insulin therapy, % yes | 17.3 (172) | 15.9 (133) | 15.4 (102) |
| BMI, kg/m2 | 31.3 (5.6) | 31.2 (5.7) | 31.2 (5.7) |
| Waist circumference, cm | 106.7 (12.7) | 106.6 (12.8) | 106.5 (12.7) |
| Serum cholesterol, mmol/l | 4.30 (0.9) | 4.31 (0.9) | 4.33 (0.9) |
| sBP, mmHg | 133.2 (16.4) | 133.3 (16.1) | 133.5 (16.3) |
| dBP, mmHg | 69.1 (9.0) | 69.3 (8.9) | 69.4 (8.9) |
| Alcohol excessa, % yes | 8.1 (84) | 7.6 (65) | 8.4 (57) |
| Ever smoked, % yes | 60.7 (527) | 59.6 (455) | 60.0 (366) |
Values are mean (SD), median (interquartile range) or proportion (n)
All variables were measured concurrently at year 1 examination of the ET2DS, except for BMI and waist circumference, which were measured at baseline
aDefined as women >14 units/week, men >21 units/week or patient disclosed history of a current or prior alcohol problem